ArticleJournal for immunotherapy of cancer2019

Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition.

Julie Voeller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.